Ken Blount

Chief Scientific Officer at Rebiotix - Roseville, MN, US

Ken Blount's Colleagues at Rebiotix
Heather McDonald

Senior Director Of Manufacturing and Technical Operations

Contact Heather McDonald

Erin Wray

Clinical Project Manager

Contact Erin Wray

Debbie Markus

Sr. Director of Quality

Contact Debbie Markus

Amy Parker

Quality Systems and Compliance Manager

Contact Amy Parker

Terry Thomas

Executive Assistant To Chief Executive Officer

Contact Terry Thomas

Brad Staskiewicz

Research Development Process Engineer

Contact Brad Staskiewicz

Kevin Cairo

Quality System Specialist I

Contact Kevin Cairo

View All Ken Blount's Colleagues
Ken Blount's Contact Details
HQ
612-335-1799
Location
Guilford, Connecticut, United States
Company
Rebiotix
Ken Blount's Company Details
Rebiotix logo, Rebiotix contact details

Rebiotix

Roseville, MN, US • 100 - 249 Employees
BioTech/Drugs

Rebiotix Inc, part of the Ferring Pharmaceuticals Group, is a clinical-stage biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases by harnessing the power of the human microbiome. Our highly skilled and dynamic team is based out of Roseville, Minnesota. Please feel free to contact us through our website at www.rebiotix.com.

Biotechnology Microbiome Drug Development Medicine Clinical Trials Regulatory Innovation Patient Support Internal Medicine Manufacturing Infectious Disease Gastroenterology Emerging Diseases Novel Technology B2B Biotech SaaS Commercial Physical Research
Details about Rebiotix
Frequently Asked Questions about Ken Blount
Ken Blount currently works for Rebiotix.
Ken Blount's role at Rebiotix is Chief Scientific Officer.
Ken Blount's email address is ***@rebiotix.com. To view Ken Blount's full email address, please signup to ConnectPlex.
Ken Blount works in the BioTech/Drugs industry.
Ken Blount's colleagues at Rebiotix are Heather McDonald, Erin Wray, Debbie Markus, Amy Parker, Terry Thomas, Brad Staskiewicz, Kevin Cairo and others.
Ken Blount's phone number is 612-335-1799
See more information about Ken Blount